{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T23:32:50Z","timestamp":1784590370821,"version":"3.55.0"},"reference-count":31,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2010,7,1]],"date-time":"2010-07-01T00:00:00Z","timestamp":1277942400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["International Journal of Antimicrobial Agents"],"published-print":{"date-parts":[[2010,7]]},"DOI":"10.1016\/j.ijantimicag.2010.02.020","type":"journal-article","created":{"date-parts":[[2010,4,19]],"date-time":"2010-04-19T08:58:06Z","timestamp":1271667486000},"page":"33-36","source":"Crossref","is-referenced-by-count":10,"title":["Efficacy of anidulafungin, caspofungin and fluconazole in the early phase of infection in a neutropenic murine invasive candidiasis model"],"prefix":"10.1016","volume":"36","author":[{"given":"Suganthini","family":"Krishnan-Natesan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elias K.","family":"Manavathu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica L.","family":"Cutright","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pranatharthi H.","family":"Chandrasekar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijantimicag.2010.02.020_bib1","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1111\/j.1439-0507.2008.01645.x","article-title":"Treatment of invasive candidiasis with echinocandins","volume":"52","author":"Gl\u00f6ckner","year":"2009","journal-title":"Mycoses"},{"key":"10.1016\/j.ijantimicag.2010.02.020_bib2","doi-asserted-by":"crossref","first-page":"2525","DOI":"10.1056\/NEJMe078078","article-title":"Echinocandins\u2014first-choice or first-line therapy for invasive candidiasis?","volume":"356","author":"Sobel","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijantimicag.2010.02.020_bib3","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1517\/14728214.11.2.231","article-title":"Emerging echinocandins for treatment of invasive fungal infections","volume":"11","author":"Turner","year":"2006","journal-title":"Expert Opin Emerg Drugs"},{"key":"10.1016\/j.ijantimicag.2010.02.020_bib4","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1517\/14656566.8.10.1479","article-title":"A comparative evaluation of properties and clinical efficacy of the echinocandins","volume":"8","author":"Kim","year":"2007","journal-title":"Expert Opin Pharmacother"},{"issue":"Suppl. 3","key":"10.1016\/j.ijantimicag.2010.02.020_bib5","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1111\/j.1439-0507.2002.tb04771.x","article-title":"The first echinocandin: caspofungin","volume":"45","author":"Cornely","year":"2002","journal-title":"Mycoses"},{"key":"10.1016\/j.ijantimicag.2010.02.020_bib6","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1093\/jac\/dkm169","article-title":"Caspofungin for the treatment of less common forms of invasive candidiasis","volume":"60","author":"Cornely","year":"2007","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2010.02.020_bib7","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1002\/cncr.21615","article-title":"Efficacy of caspofungin against invasive Candida or invasive Aspergillus infections in neutropenic patients","volume":"106","author":"Betts","year":"2006","journal-title":"Cancer"},{"issue":"Suppl. 1","key":"10.1016\/j.ijantimicag.2010.02.020_bib8","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1111\/j.1439-0507.2008.01527.x","article-title":"Efficacy of caspofungin in invasive candidiasis and candidemia\u2014de-escalation strategy","volume":"51","author":"Lichtenstern","year":"2008","journal-title":"Mycoses"},{"key":"10.1016\/j.ijantimicag.2010.02.020_bib9","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1099\/jmm.0.46452-0","article-title":"An open study of the comparative efficacy and safety of caspofungin and liposomal amphotericin B in treating invasive fungal infections or febrile neutropenia in patients with haematological malignancy","volume":"55","author":"Ellis","year":"2006","journal-title":"J Med Microbiol"},{"key":"10.1016\/j.ijantimicag.2010.02.020_bib10","doi-asserted-by":"crossref","first-page":"2225","DOI":"10.2165\/00003495-200868150-00010","article-title":"Micafungin: a review of its use in adults for the treatment of invasive and oesophageal candidiasis, and as prophylaxis against Candida infections","volume":"68","author":"Cross","year":"2008","journal-title":"Drugs"},{"key":"10.1016\/j.ijantimicag.2010.02.020_bib11","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1592\/phco.29.1.17","article-title":"Pharmacology and antifungal properties of anidulafungin, a new echinocandin","volume":"29","author":"Estes","year":"2009","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.ijantimicag.2010.02.020_bib12","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1056\/NEJMc071981","article-title":"Anidulafungin and fluconazole for candidiasis","volume":"357","author":"Nir-Paz","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijantimicag.2010.02.020_bib13","doi-asserted-by":"crossref","first-page":"2472","DOI":"10.1056\/NEJMoa066906","article-title":"Anidulafungin versus fluconazole for invasive candidiasis","volume":"356","author":"Reboli","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijantimicag.2010.02.020_bib14","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1128\/AAC.44.2.368-377.2000","article-title":"Discovery of novel antifungal (1,3)-\u03b2-d-glucan synthase inhibitors","volume":"44","author":"Onishi","year":"2000","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2010.02.020_bib15","doi-asserted-by":"crossref","first-page":"2471","DOI":"10.1128\/AAC.41.11.2471","article-title":"Identification of the FKS1 gene of Candida albicans as the essential target of 1,3-\u03b2-d-glucan synthase inhibitors","volume":"41","author":"Douglas","year":"1997","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2010.02.020_bib16","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1128\/AAC.42.5.1187","article-title":"Photoaffinity analog of the semisynthetic echinocandin LY303366: identification of echinocandin targets in Candida albicans","volume":"42","author":"Radding","year":"1998","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2010.02.020_bib17","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1086\/520980","article-title":"Micafungin versus caspofungin for treatment of candidemia and other forms of invasive candidiasis","volume":"45","author":"Pappas","year":"2007","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2010.02.020_bib18","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1093\/jac\/dkg018","article-title":"Antifungal activity of the echinocandin anidulafungin (VER002, LY303366) against yeast pathogens: a comparative study with M27-A microdilution method","volume":"51","author":"Arevalo","year":"2003","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2010.02.020_bib19","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1128\/AAC.01140-07","article-title":"Comparative in vitro activity of caspofungin and micafungin, using the method of the European Committee on Antimicrobial Susceptibility Testing (EUCAST), against yeast isolates from France (2005\u20132006)","volume":"52","author":"Dannaoui","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2010.02.020_bib20","doi-asserted-by":"crossref","first-page":"2620","DOI":"10.1128\/JCM.00566-08","article-title":"Correlation of MIC with outcome for Candida species tested against caspofungin, anidulafungin, and micafungin: analysis and proposal for interpretive MIC breakpoints","volume":"46","author":"Pfaller","year":"2008","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.ijantimicag.2010.02.020_bib21","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1128\/JCM.01901-07","article-title":"In vitro susceptibility of invasive isolates of Candida spp. to anidulafungin, caspofungin, and micafungin: six years of global surveillance","volume":"46","author":"Pfaller","year":"2008","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.ijantimicag.2010.02.020_bib22","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1128\/JCM.44.3.760-763.2006","article-title":"In vitro susceptibilities of Candida spp. to caspofungin: four years of global surveillance","volume":"44","author":"Pfaller","year":"2006","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.ijantimicag.2010.02.020_bib23","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.1128\/JCM.00493-08","article-title":"Clinical evaluation of the Sensititre YeastOne colorimetric antifungal panel for antifungal susceptibility testing of the echinocandins anidulafungin, caspofungin, and micafungin","volume":"46","author":"Pfaller","year":"2008","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.ijantimicag.2010.02.020_bib24","doi-asserted-by":"crossref","first-page":"5425","DOI":"10.1128\/JCM.43.11.5425-5427.2005","article-title":"In vitro activities of anidulafungin against more than 2500 clinical isolates of Candida spp., including 315 isolates resistant to fluconazole","volume":"43","author":"Pfaller","year":"2005","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.ijantimicag.2010.02.020_bib25","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1097\/QCO.0b013e3282f1bea3","article-title":"Impact of pharmacodynamics and pharmacokinetics on echinocandin dosing strategies","volume":"20","author":"Gumbo","year":"2007","journal-title":"Curr Opin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2010.02.020_bib26","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1128\/AAC.01061-07","article-title":"In vivo pharmacodynamic characterization of anidulafungin in a neutropenic murine candidiasis model","volume":"52","author":"Andes","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2010.02.020_bib27","doi-asserted-by":"crossref","first-page":"3695","DOI":"10.1128\/AAC.00507-06","article-title":"Anidulafungin pharmacokinetics and microbial response in neutropenic mice with disseminated candidiasis","volume":"50","author":"Gumbo","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2010.02.020_bib28","doi-asserted-by":"crossref","first-page":"2339","DOI":"10.1128\/AAC.41.11.2339","article-title":"Preliminary animal pharmacokinetics of the parenteral antifungal agent MK-0991 (L-743,872)","volume":"41","author":"Hajdu","year":"1997","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2010.02.020_bib29","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1128\/AAC.48.4.1272-1280.2004","article-title":"Disposition of caspofungin, a novel antifungal agent in mice, rats, rabbits, and monkeys","volume":"48","author":"Sandhu","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2010.02.020_bib30","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1128\/AAC.46.3.739-745.2002","article-title":"Single- and multiple-dose pharmacokinetics of caspofungin in healthy men","volume":"46","author":"Stone","year":"2002","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2010.02.020_bib31","doi-asserted-by":"crossref","first-page":"2673","DOI":"10.1128\/AAC.01596-07","article-title":"Pharmacokinetics and tissue distribution of anidulafungin in rats","volume":"52","author":"Damle","year":"2008","journal-title":"Antimicrob Agents Chemother"}],"container-title":["International Journal of Antimicrobial Agents"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857910001123?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857910001123?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T13:50:55Z","timestamp":1559051455000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924857910001123"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,7]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010,7]]}},"alternative-id":["S0924857910001123"],"URL":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2010.02.020","relation":{},"ISSN":["0924-8579"],"issn-type":[{"value":"0924-8579","type":"print"}],"subject":[],"published":{"date-parts":[[2010,7]]}}}